These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5325582)

  • 1. Cardiac and renal hemodynamic effects of debrisoquin sulfate in hypertensive patients.
    Onesti G; LaSchiazza D; Brest AN; Moyer JH
    Clin Pharmacol Ther; 1966; 7(1):17-20. PubMed ID: 5325582
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic effects of a new antihypertensive agent, guanadrel sulfate.
    Cangiano JL; Bloomfield DK
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):736-44. PubMed ID: 4984037
    [No Abstract]   [Full Text] [Related]  

  • 3. Analyses of the blood circulation after administration of propanidid.
    Doenicke A; Spiess W
    Acta Anaesthesiol Scand Suppl; 1965; 17():53-4. PubMed ID: 5325614
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties.
    Muir AL; Burton JL; Lawrie DM
    Lancet; 1969 Jul; 2(7613):181-4. PubMed ID: 4183136
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
    Reale A; Motolese M; Imhof P
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulatory effects of morphine early after open-heart surgery.
    Morrison JD; Moffitt EA; Danielson GK; Pluth JR
    J Thorac Cardiovasc Surg; 1972 Jun; 63(6):890-5. PubMed ID: 4555050
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155).
    Onesti G; Schwartz AB; Kim KE; Swartz C; Brest AN
    Circulation; 1969 Feb; 39(2):219-28. PubMed ID: 4884576
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of bradykinin on cardiac output and blood distribution of rats.
    Takács L; Albert K
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):117-21. PubMed ID: 5319631
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic effects of two beta-adrenergic blocking drugs in anesthetized intact dogs.
    Murray JF; Escobar E; Jones NL; Rapaport E
    Am Heart J; 1966 Jul; 72(1):38-49. PubMed ID: 5329023
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypotensive action of DL-(methylene-3-4) phenyl 2 hydroxy-2-acetamidine hydrocloride (LL-1418)].
    Duteil J; Sautai M; Pessonnier A; Gombert R; Assous E
    Therapie; 1969; 24(4):723-33. PubMed ID: 5822010
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal and cardiovascular effect of prostaglandin A2 in hypertensive patients.
    Hornych A; Safar M; Papanicolaou N; Meyer P; Milliez P
    Eur J Clin Invest; 1973 Sep; 3(5):391-8. PubMed ID: 4772335
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic and coronary hemodynamic effects of diphenylhydantoin.
    Rowe GG; McKenna DH; Sialer S; Corliss RJ
    Am J Med Sci; 1967 Oct; 254(4):534-41. PubMed ID: 6052849
    [No Abstract]   [Full Text] [Related]  

  • 13. HEMODYNAMIC EFFECTS OF PARGYLINE IN HYPERTENSIVE PATIENTS.
    ONESTI G; NOVACK P; RAMIREZ O; BREST AN; MOYER JH
    Circulation; 1964 Dec; 30():830-5. PubMed ID: 14246326
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 15. Radionuclide techniques in studies of cardiac performance and circulatory changes during antihypertensive treatment.
    Falch DK
    J Oslo City Hosp; 1980; 30(9-10):113-36. PubMed ID: 7003079
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of chronic and acute effects of morphine sulfate on cardiovascular function.
    Pur-Shahriari AA; Mills RA; Hoppin FG; Dexter L
    Am J Cardiol; 1967 Nov; 20(5):654-9. PubMed ID: 6053513
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
    Nayler WG; Price JM; Swann JB; McInnes I; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic and coronary hemodynamic effects of isoproterenol in control animals and those pretreated with a MAO inhibitor (pargyline hydrochloride).
    McKenna DH; Afonso S; Jaramillo CV; Crumpton CW; Rowe GG
    Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):275-82. PubMed ID: 5968511
    [No Abstract]   [Full Text] [Related]  

  • 19. [The behavior of hemodynamic values in hypertensive patients under treatment with dichlorophenylaminoimidazoline hydrochloride].
    Pozenel H
    Wien Klin Wochenschr; 1969 Mar; 81(10):187-92. PubMed ID: 4891025
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged local and systemic hemodynamic effects of hyperosmotic solutions.
    Frohlich ED
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):154-66. PubMed ID: 5941876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.